217 related articles for article (PubMed ID: 29423198)
1. MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
Selvaskandan H; Pawluczyk I; Barratt J
Clin Kidney J; 2018 Feb; 11(1):29-37. PubMed ID: 29423198
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as a therapeutic target in IgA nephropathy in Indian population.
Tripathy A; Yedla P; Vishnubhotla RV; Sekaran A; Keithi Reddy SR
Biomed Rep; 2023 May; 18(5):35. PubMed ID: 37089577
[TBL] [Abstract][Full Text] [Related]
3. The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?
Pawluczyk IZA; Selvaskandan H; Barratt J
J Clin Med; 2021 May; 10(11):. PubMed ID: 34071162
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
5. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy.
Infante B; Rossini M; Di Lorenzo A; Coviello N; Giuseppe C; Gesualdo L; Giuseppe G; Stallone G
Clin Kidney J; 2020 Oct; 13(5):758-767. PubMed ID: 33123355
[TBL] [Abstract][Full Text] [Related]
7. Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.
Gaumond L; Lamarche C; Beauchemin S; Henley N; Elftouh N; Gerarduzzi C; Laurin LP
Inflamm Res; 2024 Mar; 73(3):447-457. PubMed ID: 38291238
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in IgA nephropathy.
Yao X; Zhai Y; An H; Gao J; Chen Y; Zhang W; Zhao Z
Ren Fail; 2021 Dec; 43(1):1298-1310. PubMed ID: 34547971
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
Zhao S; Sun Y; Mao Q; Zhou C; Chen Y; Xue D
Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
11. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
12. MiR-320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy.
Li C; Shi J; Zhao Y
J Cell Biochem; 2018 Jun; 119(6):4607-4614. PubMed ID: 29266359
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis.
Li H; Chen Z; Chen W; Li J; Liu Y; Ma H; Shi M; Sun X; Yao X; Li Z; Pawluczyk IZA; Zhang S; Barratt J; Lv J; Wang K; Zhao B
J Am Soc Nephrol; 2021 Oct; 32(10):2561-2578. PubMed ID: 34479967
[TBL] [Abstract][Full Text] [Related]
14. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression.
Pawluczyk I; Nicholson M; Barbour S; Er L; Selvaskandan H; Bhachu JS; Barratt J
Kidney Int Rep; 2021 Aug; 6(8):2179-2188. PubMed ID: 34386667
[TBL] [Abstract][Full Text] [Related]
16. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F
Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407
[TBL] [Abstract][Full Text] [Related]
17. The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy.
Huang C; Li X; Wu J; Zhang W; Sun S; Lin L; Wang X; Li H; Wu X; Zhang P; Xu G; Wang H; Liu H; Liu Y; Chen D; Zhuo L; Li W; Yang H; Wang J; Wang L; Liu X
J Autoimmun; 2019 Feb; 97():100-107. PubMed ID: 30385082
[TBL] [Abstract][Full Text] [Related]
18. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA signature of patients with IgA nephropathy.
Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C
Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010
[TBL] [Abstract][Full Text] [Related]
20. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
